EMD Millipore, Samsung commit to long-term engagement; Recipharm invests in biotech;

> EMD Millipore, a division of Germany's Merck KGaA, has a new long-term deal to provide ingredients to Samsung BioLogics. Announcement

> The FDA is taking a supplement maker to court for selling its products as treatments for conditions like cancer and for not meeting manufacturing standards. Announcement

> Indian drugmakers are expected to raise their investments over the next four years to help them comply with U.S. FDA oversight. Report

> Menzies Aviation Bobba has opened a temperature-controlled facility to handle pharmaceuticals at its cargo terminal at the Kempegowda International Airport in Bangalore, India. Report

And Finally... CDMO Recipharm has a deal to make a treatment being developed by Isofol Medical and has also invested 8 million Swedish krona ($1.2 million) in the company. Release